SCHEMBL20866762

SCHEMBL20866762

COC1(c2nc(C(=N)ON)c(N3CCOCC3)s2)CCC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.30
▸ MTOR P42345 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866691 0.88 MAPK1 (0.31) —
SCHEMBL20866963 0.87 PIK3CD (0.30) PIK3CA
SCHEMBL20867257 0.85 SYK (0.31) —
SCHEMBL24612188 0.84 PIK3CD (0.30) PIK3CA
SCHEMBL20867295 0.81 — —
SCHEMBL24612210 0.72 FBP1 (0.31) —
SCHEMBL20866838 0.72 ATM (0.32) PIK3CA
SCHEMBL24612293 0.71 ATM (0.31) —
SCHEMBL18394458 0.71 KDM4E (0.42) PIK3CA
SCHEMBL20867306 0.70 ATM (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback